AMIFOSTINE Side Effects

7023660-8 | Erythema Multiforme, Radiation Skin Injury
on Sep 29, 2010 Male patient from UNITED STATES , 81 years of age, weighting 145.5 lb, was diagnosed with prophylaxis and was treated with Amifostine (View Usage). Patient experienced the following unwanted or unexpected effects: erythema multiforme, radiation skin injury. Amifostine dosage: 500 Mg Other Sq. Patient was hospitalized.

6283956-4 | Rash Maculo-papular
Patient was taking Amifostine (View Usage). Patient had the following side effects: rash maculo-papular on Jul 23, 2009 from UNITED STATES Additional patient health information: Male patient , weighting 168.0 lb, was diagnosed with dry mouth, head and neck cancer (What is head and neck cancer?) and. Amifostine dosage: 500mg M-f Sq, 32 Doses Since 6/2/09.

6203131-9 | Body Temperature Decreased, Pruritus, Rash Macular
Adverse event was reported on May 22, 2009 by a Male patient taking Amifostine (View Usage) (Dosage: 500 Mg M-f Sq 5 Doses) was diagnosed with dry mouth, hypertension and. Location: UNITED STATES , weighting 107.0 lb, After Amifostine was administered, patient had the following side effects: body temperature decreased, pruritus, rash macular.

6187888-1 | Pruritus, Rash Maculo-papular
on May 11, 2009 Male patient from UNITED STATES , weighting 133.0 lb, was diagnosed with dry mouth, head and neck cancer (What is head and neck cancer?) and was treated with Amifostine (View Usage). Patient experienced the following unwanted or unexpected effects: pruritus, rash maculo-papular. Amifostine dosage: 500mg M-f Sq (15 Doses Since 3/11/09).


6062175-0 | Rash Maculo-papular
on Feb 02, 2009 Male patient from UNITED STATES , weighting 135.0 lb, was diagnosed with dry mouth, head and neck cancer (What is head and neck cancer?) and was treated with Amifostine (View Usage). Patient had the following side effects: rash maculo-papular. Amifostine dosage: 500mg M-f Sq.

6062173-7 | Rash Macular
Patient was taking Amifostine (View Usage). After Amifostine was administered, patient had the following side effects: rash macular on Feb 02, 2009 from UNITED STATES Additional patient health information: Male patient , weighting 132.0 lb, was diagnosed with dry mouth, head and neck cancer (What is head and neck cancer?) and. Amifostine dosage: 500mg M-f Sq 6 Doses.

6051027-8 | Rash Macular
Adverse event was reported on Jan 21, 2009 by a Male patient taking Amifostine (View Usage) (Dosage: 500mg M-f Sq 9 Doses) was diagnosed with dry mouth, head and neck cancer (What is head and neck cancer?) and. Location: UNITED STATES , weighting 284.0 lb, Patient experienced the following unwanted or unexpected effects: rash macular.

6043410-1 | Rash Maculo-papular
on Jan 15, 2009 Male patient from UNITED STATES , weighting 142.0 lb, was diagnosed with dry mouth, head and neck cancer (What is head and neck cancer?) and was treated with Amifostine (View Usage). Patient had the following side effects: rash maculo-papular. Amifostine dosage: 500mg M-f Sq 6 Doses.

5920117-X | Pruritus, Rash Maculo-papular
on Oct 15, 2008 Male patient from UNITED STATES , weighting 170.0 lb, was diagnosed with dry mouth, head and neck cancer (What is head and neck cancer?) and was treated with Amifostine (View Usage). After Amifostine was administered, patient had the following side effects: pruritus, rash maculo-papular. Amifostine dosage: 500mg M-f Sq 18 Doses.

5901905-2 | Hypoaesthesia, Paraesthesia
Patient was taking Amifostine (View Usage). Patient experienced the following unwanted or unexpected effects: hypoaesthesia, paraesthesia on Aug 27, 2008 from UNITED STATES Additional patient health information: Male patient , weighting 124.0 lb, . Amifostine dosage: See B.5.. During the same period patient was treated with ERBITUX (View Erbitux Review and Erbitux Label ).

5875056-X | Cardiac Arrest, Catheter Site Erythema, Catheter Site Pain, Cerebral Thrombosis, Fall
Adverse event was reported on Sep 08, 2008 by a Male patient taking Amifostine (View Usage) (Dosage: 740 Mg/m2 Daily Iv) was diagnosed with prophylaxis and. Location: UNITED STATES , 65 years of age, weighting 220.5 lb, Patient had the following side effects: cardiac arrest (What is cardiac arrest?), catheter site erythema, catheter site pain, cerebral thrombosis, fall (What is fall?). During the same period patient was treated with MELPHALAN (180 Mg/m2 Once Iv) (View Melphalan Review and Melphalan Label ), LIPITOR (View Lipitor Review and Lipitor Label ), TOPROL XL (View Toprol-xl Review and Toprol-xl Label ), VALTREX (View Valtrex Review and Valtrex Label ), LORAZEPAM (View Lorazepam Review and Lorazepam Label ), GLIPIZIDE (View Glipizide Review and Glipizide Label ), METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ).

5875054-6 | Dyspnoea, Palpitations, Pulmonary Embolism, Tachycardia
on Sep 08, 2008 Female patient from UNITED STATES , 41 years of age, weighting 173.1 lb, was diagnosed with stem cell transplant and was treated with Amifostine (View Usage). After Amifostine was administered, patient had the following side effects: dyspnoea, palpitations, pulmonary embolism (What is pulmonary embolism?), tachycardia. Amifostine dosage: 740 Mg Daily M2 Iv. During the same period patient was treated with MELPHALAN (180 Mg Once M2 Iv) (View Melphalan Review and Melphalan Label ), VALTREX (View Valtrex Review and Valtrex Label ), ZOLOFT (View Zoloft Review and Zoloft Label ), PROTONIX (View Protonix Review and Protonix Label ), NEURONTIN (View Neurontin Review and Neurontin Label ), COUMADIN (View Coumadin Review and Coumadin Label ), CALCIUM (View Calcium Review and Calcium Label ), CARBONATE (View Carbonate Review and Carbonate Label ). Patient was hospitalized.

5875051-0 | Disease Progression, Dyspnoea, Lymphadenopathy Mediastinal, Pleural Effusion
on Sep 08, 2008 Male patient from UNITED STATES , 57 years of age, weighting 222.7 lb, was diagnosed with non-hodgkin's lymphoma and was treated with Amifostine (View Usage). Patient experienced the following unwanted or unexpected effects: disease progression, dyspnoea, lymphadenopathy mediastinal, pleural effusion. Amifostine dosage: 740 Mg Daily M2 Iv. During the same period patient was treated with MELPHALAN (240 Mg Once M2 Iv) (View Melphalan Review and Melphalan Label ), ACYCLOVIR (View Acyclovir Review and Acyclovir Label ), ADVAIR DISKUS 100/50 (View Advair Diskus 100/50 Review and Advair Diskus 100/50 Label ), ATIVAN (View Ativan Review and Ativan Label ), CALCIUM CARBONATE (View Calcium Carbonate Review and Calcium Carbonate Label ), CITALOPRAM HYDROBROMIDE (View Citalopram Hydrobromide Review and Citalopram Hydrobromide Label ), FLOMAX (View Flomax Review and Flomax Label ), LOPERAMIDE HCL (View Loperamide Hcl Review and Loperamide Hcl Label ). Patient was hospitalized.

5724841-3 | Feeding Disorder, Haematemesis, Nausea
Patient was taking Amifostine (View Usage). Patient had the following side effects: feeding disorder, haematemesis, nausea (What is nausea?) on Apr 30, 2008 from UNITED STATES Additional patient health information: Male patient , 59 years of age, . Amifostine dosage: 50 Mg Every Day Iv. During the same period patient was treated with CETUXIMAB (730 Mg Once Iv) (View Cetuximab Review and Cetuximab Label ). Patient was hospitalized.

5670688-6 | Grand Mal Convulsion
Adverse event was reported on Mar 17, 2008 by a Male patient taking Amifostine (View Usage) (Dosage: ) . Location: UNITED STATES , weighting 108.4 lb, After Amifostine was administered, patient had the following side effects: grand mal convulsion.

5636294-4 | Pruritus, Rash Maculo-papular
on Feb 20, 2008 Male patient from UNITED STATES , weighting 124.0 lb, was diagnosed with dry mouth, neoplasm malignant and was treated with Amifostine (View Usage). Patient experienced the following unwanted or unexpected effects: pruritus, rash maculo-papular. Amifostine dosage: 500 Mg M-f Sq 4 Doses Since 2/07/08.

5622593-9 | Rash Maculo-papular
on Feb 11, 2008 Female patient from UNITED STATES , weighting 163.0 lb, was diagnosed with dry mouth, neoplasm malignant and was treated with Amifostine (View Usage). Patient had the following side effects: rash maculo-papular. Amifostine dosage: 500mg M-f Sq (duration: 4 Doses Since 1/29/08).

5609089-5 | Pruritus, Rash Maculo-papular
Patient was taking Amifostine (View Usage). After Amifostine was administered, patient had the following side effects: pruritus, rash maculo-papular on Jan 30, 2008 from UNITED STATES Additional patient health information: Male patient , weighting 132.0 lb, was diagnosed with dry mouth, neoplasm malignant and. Amifostine dosage: 500mg M-f Sq 14 Doses.

5295662-3 | Eye Swelling, Graft Complication, Ocular Hyperaemia, Pruritus, Rash Maculo-papular
Adverse event was reported on Apr 10, 2007 by a Male patient taking Amifostine (View Usage) (Dosage: 500 Mg Sq Daily M-f X 18 Day) was diagnosed with neoplasm malignant and. Location: UNITED STATES , 52 years of age, weighting 149.0 lb, Patient experienced the following unwanted or unexpected effects: eye swelling, graft complication, ocular hyperaemia, pruritus, rash maculo-papular. During the same period patient was treated with RADIATION (View Radiation Review and Radiation Label ).

5109826-2 | Body Temperature Increased, Contusion, Erythema, Induration, Injection Site Pain, Skin Discolouration, Swelling, White Blood Cell Count Decreased
on Sep 18, 2006 Female patient from UNITED STATES , 68 years of age, weighting 172.8 lb, was diagnosed with prophylaxis, radiation mucositis and was treated with Amifostine (View Usage). Patient had the following side effects: body temperature increased, contusion, erythema, induration, injection site pain, skin discolouration, swelling, white blood cell count decreased. Amifostine dosage: 500 Mg Once Sq.

5093914-3 | Angina Pectoris, Malaise, Pyrexia, Rash Erythematous
on Aug 29, 2006 Male patient from UNITED STATES , 81 years of age, weighting 169.8 lb, was diagnosed with non-small cell lung cancer, gastrooesophageal reflux disease and was treated with Amifostine (View Usage). After Amifostine was administered, patient had the following side effects: angina pectoris, malaise, pyrexia, rash erythematous. Amifostine dosage: 500mg Weekly Ivpb. During the same period patient was treated with OMEPRAZOLE (40mg Qd Po) (View Omeprazole Review and Omeprazole Label ), CARBOPLATIN (View Carboplatin Review and Carboplatin Label ), PACLITAXEL (View Paclitaxel Review and Paclitaxel Label ). Patient was hospitalized.

5092119-X | Aspiration, Hypotension, Infection, Loss Of Consciousness, Lung Infiltration
Patient was taking Amifostine (View Usage). Patient experienced the following unwanted or unexpected effects: aspiration, hypotension, infection (What is infection?), loss of consciousness, lung infiltration on Aug 28, 2006 from UNITED STATES Additional patient health information: Male patient , 56 years of age, weighting 103.6 lb, . Amifostine dosage: 500mg In 2.9ml Ns Daily. During the same period patient was treated with CELEXA (View Celexa Review and Celexa Label ), ADVAIR DISKUS 100/50 (View Advair Diskus 100/50 Review and Advair Diskus 100/50 Label ), HYDROMORPHONE HCL (View Hydromorphone Hcl Review and Hydromorphone Hcl Label ), METHADONE HCL (View Methadone Hcl Review and Methadone Hcl Label ), NEURONTIN (View Neurontin Review and Neurontin Label ), TRAZODONE HCL (View Trazodone Hcl Review and Trazodone Hcl Label ), ZYPREXA (View Zyprexa Review and Zyprexa Label ). Patient was hospitalized.

5051830-7 | Pruritus, Rash Erythematous, Rash Papular
Adverse event was reported on Jul 12, 2006 by a Male patient taking Amifostine (View Usage) (Dosage: Sq 500 Mg M-f [11 Doses Since 6/11/06]) was diagnosed with squamous cell carcinoma and. Location: UNITED STATES , weighting 141.5 lb, Patient had the following side effects: pruritus, rash erythematous, rash papular. During the same period patient was treated with REGLAN (View Reglan Review and Reglan Label ), COMPAZINE (View Compazine Review and Compazine Label ).

5040676-1 | Pruritus, Rash Morbilliform
on Jun 29, 2006 Male patient from UNITED STATES , weighting 140.0 lb, was diagnosed with prophylaxis and was treated with Amifostine (View Usage). After Amifostine was administered, patient had the following side effects: pruritus, rash morbilliform. Amifostine dosage: 500 Mg /2.9 Ml Daily Pre-rt Subcutan.

5001690-5 | Abdominal Pain, Dizziness, Fatigue, Gastrointestinal Haemorrhage, Hypotension, Infection, Melaena, Nausea, Oesophagitis
on May 12, 2006 Female patient from UNITED STATES , weighting 108.2 lb, was diagnosed with amyloidosis and was treated with Amifostine (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal pain (What is abdominal pain?), dizziness (What is dizziness?), fatigue, gastrointestinal haemorrhage, hypotension, infection (What is infection?), melaena, nausea (What is nausea?), oesophagitis. Amifostine dosage: 2040 Mg. During the same period patient was treated with MELPHALAN (170 Mg) (View Melphalan Review and Melphalan Label ). Patient was hospitalized.

4983727-2 | Neutrophil Count Abnormal, Oesophagitis, Renal Failure Acute, White Blood Cell Disorder
Patient was taking Amifostine (View Usage). Patient had the following side effects: neutrophil count abnormal, oesophagitis, renal failure acute, white blood cell disorder on Apr 25, 2006 from UNITED STATES Additional patient health information: Female patient , weighting 108.2 lb, was diagnosed with amyloidosis and. Amifostine dosage: 2040 Mg. During the same period patient was treated with MELPHALAN (170 Mg) (View Melphalan Review and Melphalan Label ). Patient was hospitalized.

4981868-7 | Nausea, Neutrophil Count Abnormal, Oesophagitis, Renal Failure Acute, White Blood Cell Disorder
Adverse event was reported on Apr 24, 2006 by a Female patient taking Amifostine (View Usage) (Dosage: 2040 Mg) was diagnosed with amyloidosis and. Location: UNITED STATES , weighting 108.2 lb, After Amifostine was administered, patient had the following side effects: nausea (What is nausea?), neutrophil count abnormal, oesophagitis, renal failure acute, white blood cell disorder. During the same period patient was treated with MELPHALAN (170 Mg) (View Melphalan Review and Melphalan Label ). Patient was hospitalized.

4911882-9 | Rash Maculo-papular
on Feb 13, 2006 Female patient from UNITED STATES , weighting 206.0 lb, was diagnosed with bone neoplasm, dry mouth, neck mass and was treated with Amifostine (View Usage). Patient experienced the following unwanted or unexpected effects: rash maculo-papular. Amifostine dosage: 500mg Sq M-f (20 Doses Since 1/10/06).

4902013-X | Laryngeal Oedema, Swollen Tongue
on Feb 02, 2006 Male patient from UNITED STATES , weighting 144.0 lb, was diagnosed with dry mouth and was treated with Amifostine (View Usage). Patient had the following side effects: laryngeal oedema, swollen tongue. Amifostine dosage: 500mg Sq Daily.

4902012-8 | Pyrexia, Rash, Rash Papular, Rash Pruritic, Urinary Tract Infection
Patient was taking Amifostine (View Usage). After Amifostine was administered, patient had the following side effects: pyrexia, rash (What is rash?), rash papular, rash pruritic, urinary tract infection (What is urinary tract infection?) on Feb 02, 2006 from UNITED STATES Additional patient health information: Female patient , weighting 256.0 lb, was diagnosed with cervix carcinoma recurrent and. Amifostine dosage: 500mg Sq M-f.

4877392-2 | Abasia, Monarthritis, Neuropathy, Neuropathy Peripheral, Oedema Peripheral, Pain, Purulent Discharge, Staphylococcal Infection, White Blood Cell Count Increased
Adverse event was reported on Jan 09, 2006 by a Female patient taking Amifostine (View Usage) (Dosage: See Image) was diagnosed with neoplasm and. Location: UNITED STATES , 63 years of age, weighting 137.3 lb, Patient experienced the following unwanted or unexpected effects: abasia, monarthritis, neuropathy, neuropathy peripheral, oedema peripheral, pain (What is pain?), purulent discharge, staphylococcal infection (What is staphylococcal infection?), white blood cell count increased. Patient was hospitalized.

4874821-5 | Arthritis Bacterial, Monarthritis, Pathogen Resistance, Staphylococcal Infection
on Jan 03, 2006 Female patient from UNITED STATES , weighting 137.3 lb, was diagnosed with neoplasm and was treated with Amifostine (View Usage). Patient had the following side effects: arthritis bacterial, monarthritis, pathogen resistance, staphylococcal infection (What is staphylococcal infection?). Amifostine dosage: See Image. Patient was hospitalized.

4856760-9 | Rash Erythematous, Rash Papular, Rash Pruritic
on Dec 15, 2005 Male patient from UNITED STATES , 48 years of age, weighting 144.0 lb, was diagnosed with dry mouth and was treated with Amifostine (View Usage). After Amifostine was administered, patient had the following side effects: rash erythematous, rash papular, rash pruritic. Amifostine dosage: 500 Mg Sq M-f Prior To Rt X 5 Doses.

4847098-4 | Chest Pain, Coronary Artery Thrombosis, Hypoxia, Procedural Complication, Stem Cell Transplant
Patient was taking Amifostine (View Usage). Patient experienced the following unwanted or unexpected effects: chest pain (What is chest pain?), coronary artery thrombosis, hypoxia, procedural complication, stem cell transplant on Dec 06, 2005 from UNITED STATES Additional patient health information: Male patient , weighting 197.1 lb, was diagnosed with amyloidosis and. Amifostine dosage: See Image. During the same period patient was treated with G CSF (FILGRASTIM, AMGEN) (See Image) (View G-csf (filgrastim, Amgen) Review and G-csf (filgrastim, Amgen) Label ), MELPHALAN (See Image) (View Melphalan Review and Melphalan Label ).

4834062-4 | Erythema, Rash Macular, Skin Reaction
Adverse event was reported on Nov 18, 2005 by a Male patient taking Amifostine (View Usage) (Dosage: 500 Mg Sq Daily M-t Prior To Rt Six Doses Since 11/09/05) was diagnosed with dry mouth, neoplasm malignant and. Location: UNITED STATES , 46 years of age, weighting 129.0 lb, Patient had the following side effects: erythema, rash macular, skin reaction. During the same period patient was treated with COMPAZINE (View Compazine Review and Compazine Label ), REGLAN (View Reglan Review and Reglan Label ).

4821586-9 | Nausea, Rash Erythematous, Rash Pruritic
on Nov 03, 2005 Male patient from UNITED STATES , 49 years of age, weighting 121.0 lb, was diagnosed with dry mouth, neoplasm malignant and was treated with Amifostine (View Usage). After Amifostine was administered, patient had the following side effects: nausea (What is nausea?), rash erythematous, rash pruritic. Amifostine dosage: 500 Mg Sq Q Day M-f 18 Doses.

4816639-5 | Blood Pressure Immeasurable, Cardio-respiratory Arrest, Hypotension, Loss Of Consciousness, Respiration Abnormal, Vision Blurred
on Oct 31, 2005 Male patient from UNITED STATES , weighting 141.5 lb, was diagnosed with amyloidosis and was treated with Amifostine (View Usage). Patient experienced the following unwanted or unexpected effects: blood pressure immeasurable, cardio-respiratory arrest, hypotension, loss of consciousness, respiration abnormal, vision blurred. Amifostine dosage: See Image. During the same period patient was treated with MELPHALAN (See Image) (View Melphalan Review and Melphalan Label ). Patient was hospitalized.

4786876-7 | Rash Maculo-papular
Patient was taking Amifostine (View Usage). Patient had the following side effects: rash maculo-papular on Sep 30, 2005 from UNITED STATES Additional patient health information: Male patient , 31 years of age, weighting 170.0 lb, was diagnosed with dry mouth, mucosal inflammation, neoplasm malignant and. Amifostine dosage: 500 Mg Sq Daily M-f Prior To Rt.

4771509-6 | Rash Maculo-papular
Adverse event was reported on Sep 14, 2005 by a Male patient taking Amifostine (View Usage) (Dosage: 500 Mg Sq (m-f)) was diagnosed with neoplasm malignant and. Location: UNITED STATES , weighting 233.0 lb, After Amifostine was administered, patient had the following side effects: rash maculo-papular.

4752230-7 | Asthenia, Bundle Branch Block Left, Cardiac Amyloidosis, Chest Pain, Dehydration, Febrile Neutropenia, Infection, Metabolic Disorder, Myocardial Ischaemia
on Aug 22, 2005 Male patient from UNITED STATES , 66 years of age, weighting 204.6 lb, was diagnosed with amyloidosis and was treated with Amifostine (View Usage). Patient experienced the following unwanted or unexpected effects: asthenia, bundle branch block left, cardiac amyloidosis, chest pain (What is chest pain?), dehydration, febrile neutropenia, infection (What is infection?), metabolic disorder (What is metabolic disorder?), myocardial ischaemia. Amifostine dosage: See Image. During the same period patient was treated with MELPHALAN (See Image) (View Melphalan Review and Melphalan Label ), COLACE (View Colace Review and Colace Label ). Patient was hospitalized.

4712786-7 | Arthralgia, Asthenia, Blood Count Abnormal, Culture Stool Positive, Dehydration, Enterobacter Infection, Febrile Neutropenia, Hepatic Cirrhosis
on Jul 11, 2005 Male patient from UNITED STATES , 70 years of age, weighting 183.0 lb, was diagnosed with hypopharyngeal cancer and was treated with Amifostine (View Usage). Patient had the following side effects: arthralgia, asthenia, blood count abnormal, culture stool positive, dehydration, enterobacter infection, febrile neutropenia, hepatic cirrhosis. Amifostine dosage: 500 Mg, Daily, Iv. During the same period patient was treated with CISPLATIN (View Cisplatin Review and Cisplatin Label ). Patient was hospitalized.

4705066-7 | Stevens-johnson Syndrome
Patient was taking Amifostine (View Usage). After Amifostine was administered, patient had the following side effects: stevens-johnson syndrome on Jun 30, 2005 from Additional patient health information: Female patient , 49 years of age, . Amifostine dosage: .

4703035-4 | Nausea
Adverse event was reported on Jun 28, 2005 by a Male patient taking Amifostine (View Usage) (Dosage: 500 Mg Iv Push) . Location: , 36 years of age, weighting 230.0 lb, Patient experienced the following unwanted or unexpected effects: nausea (What is nausea?). Patient was hospitalized.

4698992-9 | Malaise, Nausea
on Jun 22, 2005 Male patient from , 36 years of age, weighting 230.0 lb, was treated with Amifostine (View Usage). Patient had the following side effects: malaise, nausea (What is nausea?). Amifostine dosage: . Patient was hospitalized.

4677608-1 | Asthenia, Bundle Branch Block Left, Chest Pain, Dehydration, Dizziness, Febrile Neutropenia, Metabolic Disorder, Neuropathy Peripheral, Orthostatic Hypotension
on May 27, 2005 Male patient from , weighting 204.6 lb, was diagnosed with amyloidosis and was treated with Amifostine (View Usage). After Amifostine was administered, patient had the following side effects: asthenia, bundle branch block left, chest pain (What is chest pain?), dehydration, dizziness (What is dizziness?), febrile neutropenia, metabolic disorder (What is metabolic disorder?), neuropathy peripheral, orthostatic hypotension. Amifostine dosage: 740 Mg/m2 On Day -2 For 5 Minuites. During the same period patient was treated with MELPHALAN (Given In A Single Infusion For 5 Minutes At 740 Mg/m2 Administered 15 To 30 Minutes After Amifostins) (View Melphalan Review and Melphalan Label ), COLACE (View Colace Review and Colace Label ).

4674171-6 | Bundle Branch Block Left, Cardiac Amyloidosis, Chest Pain, Dizziness, Electrocardiogram Abnormal, Myocardial Infarction, Orthostatic Hypotension
Patient was taking Amifostine (View Usage). Patient experienced the following unwanted or unexpected effects: bundle branch block left, cardiac amyloidosis, chest pain (What is chest pain?), dizziness (What is dizziness?), electrocardiogram abnormal, myocardial infarction, orthostatic hypotension on May 24, 2005 from Additional patient health information: Male patient , weighting 204.6 lb, . Amifostine dosage: 740 Mg/m2 On Day -2 For 5 Minutes. During the same period patient was treated with MELPHALAN (Given As A Single Infusion For 5 Minutes At 740 Mg/m2 Administered 15 To 30 Minutes After The Amifos) (View Melphalan Review and Melphalan Label ), ALLEGRA (View Allegra Review and Allegra Label ), AMITRIPTYLINE (View Amitriptyline Review and Amitriptyline Label ), ANUSOL HC (View Anusol Hc Review and Anusol Hc Label ), COLACE (View Colace Review and Colace Label ), COMPZINE (View Compzine Review and Compzine Label ), FLONASE (View Flonase Review and Flonase Label ), DYHYDROCHLOROTHIAZIDE (View Dyhydrochlorothiazide Review and Dyhydrochlorothiazide Label ).

4634649-8 | Nausea
Adverse event was reported on Apr 13, 2005 by a Male patient taking Amifostine (View Usage) (Dosage: Subcutaneous; 500.0) was diagnosed with mucosal inflammation, prophylaxis and. Location: , 56 years of age, Patient had the following side effects: nausea (What is nausea?). During the same period patient was treated with CISPLATIN/5 FU (View Cisplatin/5-fu Review and Cisplatin/5-fu Label ). Patient was hospitalized.

4575413-8 | Fatigue, Rash Erythematous, Rash Pruritic
on Jan 28, 2005 Male patient from , 56 years of age, weighting 251.0 lb, was diagnosed with tonsil cancer and was treated with Amifostine (View Usage). After Amifostine was administered, patient had the following side effects: fatigue, rash erythematous, rash pruritic. Amifostine dosage: 500mg Subcutaneous. During the same period patient was treated with CISPLATIN (View Cisplatin Review and Cisplatin Label ), ALOXI (View Aloxi Review and Aloxi Label ), MANNITOL (View Mannitol Review and Mannitol Label ), EMEND (View Emend Review and Emend Label ).